1. Home
  2. RDHL vs XWEL Comparison

RDHL vs XWEL Comparison

Compare RDHL & XWEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RDHL
  • XWEL
  • Stock Information
  • Founded
  • RDHL 2009
  • XWEL 2006
  • Country
  • RDHL Israel
  • XWEL United States
  • Employees
  • RDHL N/A
  • XWEL N/A
  • Industry
  • RDHL Biotechnology: Pharmaceutical Preparations
  • XWEL Other Consumer Services
  • Sector
  • RDHL Health Care
  • XWEL Consumer Discretionary
  • Exchange
  • RDHL Nasdaq
  • XWEL Nasdaq
  • Market Cap
  • RDHL 6.8M
  • XWEL 5.7M
  • IPO Year
  • RDHL N/A
  • XWEL N/A
  • Fundamental
  • Price
  • RDHL $2.45
  • XWEL $0.97
  • Analyst Decision
  • RDHL
  • XWEL
  • Analyst Count
  • RDHL 0
  • XWEL 0
  • Target Price
  • RDHL N/A
  • XWEL N/A
  • AVG Volume (30 Days)
  • RDHL 121.9K
  • XWEL 95.1K
  • Earning Date
  • RDHL 04-11-2025
  • XWEL 05-14-2025
  • Dividend Yield
  • RDHL N/A
  • XWEL N/A
  • EPS Growth
  • RDHL N/A
  • XWEL N/A
  • EPS
  • RDHL N/A
  • XWEL N/A
  • Revenue
  • RDHL $3,707,000.00
  • XWEL $33,833,000.00
  • Revenue This Year
  • RDHL $224.90
  • XWEL $22.75
  • Revenue Next Year
  • RDHL $82.69
  • XWEL N/A
  • P/E Ratio
  • RDHL N/A
  • XWEL N/A
  • Revenue Growth
  • RDHL N/A
  • XWEL 11.79
  • 52 Week Low
  • RDHL $2.40
  • XWEL $0.74
  • 52 Week High
  • RDHL $20.28
  • XWEL $2.70
  • Technical
  • Relative Strength Index (RSI)
  • RDHL 26.68
  • XWEL 43.40
  • Support Level
  • RDHL $2.64
  • XWEL $0.95
  • Resistance Level
  • RDHL $2.90
  • XWEL $1.33
  • Average True Range (ATR)
  • RDHL 0.23
  • XWEL 0.20
  • MACD
  • RDHL 0.07
  • XWEL 0.01
  • Stochastic Oscillator
  • RDHL 6.76
  • XWEL 30.77

About RDHL Redhill Biopharma Ltd.

Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.

About XWEL XWELL Inc.

XWELL Inc is a health and wellness holding company. It is an airport retailer of spa services through XpresSpa locations, offering travelers premium spa services, including massage, nail, and skincare, as well as spa and travel products. It operates four reportable operating segments: XpresSpa. XpresTest, Naples Wax Center and Treat. XpresSpa provides travelers premium spa services, including massage, nail and skin care, as well as spa and travel products.. Treat is a travel health and wellness brand that offers in-airport spa. XpresTest provides COVID-19 screening and diagnostic testing in partnership with the CDC. Naples Wax Center operates three high-performing locations with core products and service offerings from face and body waxing to a range of skincare and cosmetic products.

Share on Social Networks: